Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma-Reference-Cited by-同舟云学术

Initial report of a phase II study with R-FND followed by ibritumomab tiuxetan radioimmunotherapy and rituximab maintenance in patients with untreated high-risk follicular lymphoma

Published:2020-09-14 Issue:1 Volume:62 Page:58-67
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Samaniego Felipe¹,McLaughlin Peter¹,Neelapu Sattva S.¹,Feng Lei¹,Fanale Michelle¹,Nastoupil Loretta¹,Rodriguez Maria Alma¹,Pro Barbara¹,Taylor Erin¹,Hagemeister Fredrick B.¹,Fowler Nathan¹^ORCID

Affiliation:

1. The University of Texas MD Anderson Cancer Center, Houston, Texas

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2020.1821005

Reference24 articles.

1. High ten-year remission rates following rituximab, fludarabine, mitoxantrone and dexamethasone (R-FND) with interferon maintenance in indolent lymphoma: Results of a randomized Study

2. Long-Term Results of the FOLL05 Trial Comparing R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Symptomatic Follicular Lymphoma

3. Long‐term overall‐ and progression‐free survival after pentostatin, cyclophosphamide and rituximab therapy for indolent non‐Hodgkin lymphoma

4. Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

5. Follicular Lymphoma International Prognostic Index

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New PET Tracers for Lymphoma;PET Clinics;2024-10

2. A Systematic Review of Clinical Applications of Anti-CD20 Radioimmunotherapy for Lymphoma;The Oncologist;2024-01-11

3. Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review;Current Cancer Therapy Reviews;2024-01

4. Maintenance and consolidation strategies for patients with untreated advanced follicular lymphoma: A systematic review and network meta‐analysis of randomized trials;Cancer;2023-12-02